Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Arterial Hypertension
MENU
Shortcuts Submit an article Author Guidelines Ahead Of Print Reviewers 2022

open access

Vol 10, No 5 (2006)
Original paper
Published online: 2006-09-13
View PDF (Polish) Download PDF file
Get Citation

Treatment effects in primary hyperaldosteronism

Tomasz Dobrucki, Mariola Pęczkowska, Hanna Janaszek-Sitkowska, Marek Kabat, Aleksander Prejbisz, Piotr Hoffman, Magdalena Makowiecka-Cieśla, Magdalena Januszewicz, Ryszard Mielniczuk, Andrzej Januszewicz, Tomasz Zieliński
Nadciśnienie tętnicze 2006;10(5):392-402.

open access

Vol 10, No 5 (2006)
Prace oryginalne
Published online: 2006-09-13

Abstract

Background Primary aldosteronism is the syndrome resulting from the autonomous hypersecretion of aldosterone. There is a lack of data concerning follow-up of patients with primary aldosteronism. Therefore, the aim of the study was to perform follow-up of patients with primary aldosteronism in relation to biochemical parameters and target organ damage.
Material and methods We evaluated 62 patients with primary aldosteronism (PA) diagnosed and treated in the Department of Hypertension, Institute of Cardiology, Warsaw, Poland. Clinical characteristics, biochemical, serum aldosterone level, plasma renin activity as well as echocardiographic parameters and blood pressure (ABPM) were evaluated at baseline and in the follow-up. Patients were divided into two group based on the type of underlying pathology and treatment type - adenoma of adrenal cortex (APA) treated surgically and idiopathic adrenal hyperplasia (IHA) treated medically (spironolactone).
Results Surgical treatment of the adenoma of adrenal cortex and medical treatment of idiopathic adrenal hyperplasia resulted in the improvement of BP control. In the follow-up APA group was characterized by lower diastolic BP level but not systolic BP level as compared with IHA group. Left ventricular mass index decreased significantly in the APA group but not in the IHA group. There was a correlation between left ventricular mass index and systolic BP level both in the APA and IHA group.
Conclusions Treatment of both adenoma of adrenal cortex and idiopathic adrenal hyperplasia resulted in the improvement of BP control. Decrease of left ventricular index was observed in patients with adenoma but not in patients with hyperplasia.

Abstract

Background Primary aldosteronism is the syndrome resulting from the autonomous hypersecretion of aldosterone. There is a lack of data concerning follow-up of patients with primary aldosteronism. Therefore, the aim of the study was to perform follow-up of patients with primary aldosteronism in relation to biochemical parameters and target organ damage.
Material and methods We evaluated 62 patients with primary aldosteronism (PA) diagnosed and treated in the Department of Hypertension, Institute of Cardiology, Warsaw, Poland. Clinical characteristics, biochemical, serum aldosterone level, plasma renin activity as well as echocardiographic parameters and blood pressure (ABPM) were evaluated at baseline and in the follow-up. Patients were divided into two group based on the type of underlying pathology and treatment type - adenoma of adrenal cortex (APA) treated surgically and idiopathic adrenal hyperplasia (IHA) treated medically (spironolactone).
Results Surgical treatment of the adenoma of adrenal cortex and medical treatment of idiopathic adrenal hyperplasia resulted in the improvement of BP control. In the follow-up APA group was characterized by lower diastolic BP level but not systolic BP level as compared with IHA group. Left ventricular mass index decreased significantly in the APA group but not in the IHA group. There was a correlation between left ventricular mass index and systolic BP level both in the APA and IHA group.
Conclusions Treatment of both adenoma of adrenal cortex and idiopathic adrenal hyperplasia resulted in the improvement of BP control. Decrease of left ventricular index was observed in patients with adenoma but not in patients with hyperplasia.

Full Text:

View PDF (Polish) Download PDF file
Get Citation

Keywords

primary aldosteronism; treatment; clinical outcomes

About this article
Title

Treatment effects in primary hyperaldosteronism

Journal

Arterial Hypertension

Issue

Vol 10, No 5 (2006)

Article type

Original paper

Pages

392-402

Published online

2006-09-13

Page views

717

Article views/downloads

1648

Bibliographic record

Nadciśnienie tętnicze 2006;10(5):392-402.

Keywords

primary aldosteronism
treatment
clinical outcomes

Authors

Tomasz Dobrucki
Mariola Pęczkowska
Hanna Janaszek-Sitkowska
Marek Kabat
Aleksander Prejbisz
Piotr Hoffman
Magdalena Makowiecka-Cieśla
Magdalena Januszewicz
Ryszard Mielniczuk
Andrzej Januszewicz
Tomasz Zieliński

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl